Best practice suggests you develop a process to identify, quantify and inventory the risks of your high-value medicines. Start with creating an inventory, estimate the likelihood and severity of each drug risk, aggregate the risks, and rank them in priority order.
We will work closely with you to conduct a more comprehensive assessment using product data. Our consultative approach will help you identify your product’s risk profile and help uncover hidden gaps in your supply chain that leave you vulnerable to counterfeiting activities.
A managing director will contact you in the next few days to schedule a consultation.